4.3 Article

Peripheral metabolism of [18F]FDDNP and cerebral uptake of its labelled metabolites

Journal

NUCLEAR MEDICINE AND BIOLOGY
Volume 35, Issue 8, Pages 869-874

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.nucmedbio.2008.09.002

Keywords

[(18)F]FDDNP; Amyloid; Metabolism; BBB transport; PET

Funding

  1. DiMI [LSHB-CT-2005-512146]

Ask authors/readers for more resources

[(18)F]FDDNP is a positron emission tomography (PET) tracer for determining amyloid plaques and neurofibrillary tangles in the brain in vivo. in order to quantify binding of this tracer properly, a metabolite-corrected plasma input function is required. The purpose of the present Study was to develop a sensitive method for measuring [(18)F]FDDNP and its radiolabelled metabolites in plasma. The second aim was to assess whether these radiolabelled metabolites enter the brain. In humans, there was extensive metabolism of [(18)F]FDDNP. After 10 min, more than 90% of plasma radioactivity was identified as polar (18)F-labelled fragments, probably formed from N-dealkylation of [(18)F]FDDNP. These labelled metabolites were reproduced in vitro using human hepatocytes. PET studies in rats showed that these polar metabolites can penetrate the blood-brain barrier and result in uniform brain uptake. (c) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available